Body composition and chemo dosing in gynecologic cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how body composition (like muscle and fat) affects chemotherapy dosing and treatment results for people with endometrial or ovarian cancer. It might help doctors give a more personalized dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have endometrial or ovarian cancer confirmed by biopsy.
- You are between 20 and 80 years old.
- You had a CT scan of your belly within 3 months before starting treatment.
- Your blood counts and organ function are within a certain range.
- You are feeling well enough for everyday activities (ECOG 0-2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether body fat and muscle (body composition) change how well certain chemotherapy works after surgery for early breast cancer. You may be considered if you are planned to receive docetaxel as adjuvant (after-surgery) chemotherapy and have recent CT scan images.
This study looks at how a person's body composition (muscle and fat) affects how well they stay still during daily radiation sessions. The goal is to improve treatment accuracy and reduce side effects for cancer patients.
This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.
This study looks at how body composition (like fat and muscle) changes in people with obesity-related cancers and how that affects their health outcomes. Researchers want to track these changes from the time of diagnosis through treatment.
This study tests whether a structured exercise program during chemotherapy can help prevent physical decline (“immobility,” like getting weaker or moving less) in people with certain ovarian or endometrial cancers. If you’re eligible, you may be guided to exercise while receiving standard chemo, and you’ll have blood tests to track changes.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
Hear when a new Search MeSH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.